Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2003
11/20/2003US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients
11/20/2003US20030213942 Photochromic fluorescent polymer and preparation method thereof
11/20/2003US20030213164 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
11/20/2003US20030213071 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362850A1 Oxime ether compound and agricultural or horticultural bactericide
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP1362076A1 Metallic thiacalix 4]arene complexes
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1361879A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1220848B1 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003US6649778 Methods of preparing amino acid taxane derivatives and polymer conjugates containing the same
11/18/2003US6649777 C2 substituted taxanes
11/18/2003US6649772 3,6,9-Trisubstituted carbazoles for light emitting diodes
11/18/2003US6649770 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649638 Prenylation inhibitors and methods of their synthesis and use
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649632 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-propionyl-10-deacetyl Baccatin III; anticarcinogenic agents
11/18/2003US6649626 Stimulants of gamma -aminobutyric acid receptors; psychological disorders
11/18/2003US6649623 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093241A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003093223A1 Biphenyl carboxamides
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003053331A3 Protease inhibitors
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003028727A9 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212276 Process for the preparation of 7-substituted-3 quinolinecarbonitriles
11/13/2003US20030212121 Antiproliferative agents; anticancer agents; autoimmune diseases; cardiovascular disorders
11/13/2003US20030212119 Novel glucagon receptor antagonists/inverse agonists
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212110 Calcilytic compounds
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212089 Arylindenopyridines and related therapeutic and prophylactic methods
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212069 Antithrombotic amides
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483529A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1037881B1 Process of preparing substituted pyrimidinones
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP1007524B1 Indole derivatives as 5-ht1b and 5-ht1d agonists
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1454908A Novel conductive polymer, sensor applicating said polymer and method for applicating said sensor to detect target molecular
11/12/2003CN1127501C Indole and 2,3-dihydroninbole derivatives, their preparation and use
11/12/2003CN1127498C Pyridine derivatives, process for preparing the same, and intermediate therefor
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 523